News and Events
News and Events
You may sort news and events by title or recency. If you wish to view only news, please select the news link from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the left.
- Sort by: Most Recent
- Title
-
QUINTILES ESTABLISHES EMERGING COMPANIES INSTITUTE
November 7, 1995 - Quintiles Transnational Corp. (Nasdaq-NNM: QTRN) announced today the establishment of the Quintiles Emerging Companies Institute to offer small, specialized companies access to a full range of medical product development services and expert consultation. The Quintiles Emerging Companies Institute will provide customized product development services to the emerging companies market segment and will provide growth opportunities for Quintiles' contract research services. -
QUINTILES TAKES OVER DRUG DEVELOPMENT FACILITY IN SCOTLAND
March 6, 1995 - Quintiles Transnational Corp. (NASDAQ-NNM:QTRN) announced that a subsidiary, Quintiles Scotland Ltd., today completed agreements to acquire certain assets of a drug development facility located in Edinburgh, Scotland from Syntex Pharmaceuticals Limited, a member of the Roche group based in Basle, Switzerland. Quintiles previously had announced that it had entered into a letter of intent to acquire the facility. -
QUINTILES CONSIDERS ACQUISITION IN SCOTLAND
January 17, 1995 - Quintiles Transnational Corp. announced today that its subsidiary, Quintiles (UK ) Limited, has signed a non-binding letter of intent to acquire certain assets of a drug development facility from Syntex Pharmaceuticals Limited, a member of the Roche group in Basle, Switzerland. The facility is located in Edinburgh, Scotland. Pursuant to the proposed agreement, Quintiles would employ approximately 200 existing Syntex employees. The proposed transaction is subject to the negotiation and execution of a definitive agreement and other approvals.
Page 1 of 1 (3 items)